• Nicole Ruggiero

Clostridium difficile vaccine development efforts

Dr. Killeen (CEO) will be presenting at Vaccines Research And Development, November 19, 2019, at the Crowne Plaza Boston.

12:10-12:35 Prophylactic and therapeutic vaccine approach targeting C. difficile infection and relapse. Kevin Killeen, Chief Scientific Officer, Matrivax R&D Corp

36 views0 comments

© 2020 Matrivax Research and Development Corporation

650 Albany Street, Suite 117, Boston, MA 02118